This article was originally published in The Tan Sheet
First quarter 2001 net loss down 73.6% to $7.9 mil. while sales jump 21.9% to $12.8 mil. compared to year-ago quarter, company announces during May 15 analysts call. President/CEO Fred Toney says health products retailer should break even in 2002 as it has reached a private debt refinancing agreement worth roughly $3.4 mil. Healthcentral also has scheduled a May 31 NASDAQ hearing to approve 1-for-50 reverse stock split to keep company listed
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC